Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Before colonoscopy AI can progress from lab to clinic on a broad scale—and win regulatory approvals along the way—it has to show its diagnostic mettle in numerous large clinical trials conducted at multiple facilities.
Emergency physicians have a tough time identifying patients who have Crohn’s disease and truly need a CT scan to pinpoint the cause of acute abdominal distress.
Broadening clinician access to the health histories of patients’ parents and grandparents would help ward off or better treat numerous chronic illnesses common to middle-aged adults in the U.S.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.